investigational therapies

Related by string. * Investigational : Investigational Device Exemption IDE . investigational compound . investigational compounds . Investigational Device Exemption . investigational mTOR inhibitor . Investigational NDAs / THERAPIES . Therapies . Therapie : vaccines biologic therapies . biologic therapies . stem cell therapies . regenerative medicine therapies . CAM therapies * *

Related by context. Frequent words. (Click for all words.) 68 CCX# 68 Azedra 67 MOZOBIL 67 pertuzumab 67 therapeutic monoclonal antibodies 67 Pirfenidone 66 registrational 66 ATL# [001] 65 theranostics 65 myeloproliferative disorders 65 tezampanel 65 Icatibant 65 Hepatitis C HCV 65 MAXY G# 65 deforolimus 65 CA4P 65 therapeutic regimens 65 Allovectin 7 R 64 GLPG# 64 Amrubicin 64 Carfilzomib 64 biologic therapies 64 elotuzumab 64 ponatinib 64 CR# vcMMAE 64 PLX cells 64 tanespimycin 64 SUTENT 64 EGFR inhibitors 64 Stedivaze 64 non alcoholic steatohepatitis 63 Amigal 63 pralatrexate 63 OncoVEX GM CSF 63 romidepsin 63 oncology indications 63 #ME# 63 liprotamase 63 omacetaxine 63 Neuradiab 63 AA amyloidosis 63 anticancer compound 63 Diamyd ® 63 neuroprotective properties 63 immunologic diseases 63 anticancer therapy 63 diabetic neuropathic pain 63 Virulizin R 63 talactoferrin 63 mTOR inhibitor 63 hematological cancers 63 tyrosine kinase inhibitor 63 BAY #-# 63 Zolinza 63 ALN VSP 63 PXD# 63 Herceptin trastuzumab 62 lupus nephritis 62 R sorafenib tablets 62 Leukine 62 Sym# 62 MORAb 62 immune modulation 62 immunomodulatory 62 immunotherapeutics 62 multiple sclerosis rheumatoid arthritis 62 investigational compounds 62 idiopathic pulmonary fibrosis IPF 62 Cethrin 62 therapeutics 62 anti fibrotic 62 rNAPc2 62 MEK inhibitor 62 immuno inflammatory diseases 62 KRN# 62 Poly ICR 62 secondary hyperparathyroidism 62 ALN TTR# 62 IMC A# 62 Torisel 62 arterial thrombosis 62 molecular profiling 62 dermatological diseases 62 HCV protease inhibitor 62 Revimmune 62 refractory Hodgkin lymphoma 62 Onalta 62 gastrointestinal stromal tumors 62 calcineurin inhibitors 62 antithrombotic 62 optimal dosing 62 LY# [003] 62 mRCC 62 Nexavar ® 62 angiogenesis inhibitor 61 fibrotic diseases 61 hepatitis C HCV 61 atacicept 61 solid organ transplantation 61 humanized monoclonal antibody 61 immunomodulator

Back to home page